OFLOXACIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ofloxacin, and what generic alternatives are available?
Ofloxacin is a drug marketed by Bedford, Altaire Pharms Inc, Alvogen, Amneal, Apotex Inc, Bausch And Lomb, Caplin, Epic Pharma Llc, Fdc Ltd, Mankind Pharma, Micro Labs, Sandoz, Sentiss, Somerset, Bausch And Lomb Inc, Hikma, Somerset Theraps Llc, Cadila Pharms Ltd, Chartwell Rx, Dr Reddys Labs Ltd, Ranbaxy Labs Ltd, and Teva. and is included in thirty NDAs.
The generic ingredient in OFLOXACIN is ofloxacin. There are seventy-eight drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the ofloxacin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ofloxacin
A generic version of OFLOXACIN was approved as ofloxacin by CHARTWELL RX on September 2nd, 2003.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for OFLOXACIN?
- What are the global sales for OFLOXACIN?
- What is Average Wholesale Price for OFLOXACIN?
Summary for OFLOXACIN
| US Patents: | 0 |
| Applicants: | 22 |
| NDAs: | 30 |
| Finished Product Suppliers / Packagers: | 31 |
| Raw Ingredient (Bulk) Api Vendors: | 167 |
| Clinical Trials: | 37 |
| Patent Applications: | 4,827 |
| Drug Prices: | Drug price information for OFLOXACIN |
| Drug Sales Revenues: | Drug sales revenues for OFLOXACIN |
| DailyMed Link: | OFLOXACIN at DailyMed |
Recent Clinical Trials for OFLOXACIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| IVIEW Therapeutics Inc. | Phase 2 |
| Jagiellonian University | N/A |
| Centre Hospitalier Universitaire, Amiens | N/A |
Pharmacology for OFLOXACIN
| Drug Class | Quinolone Antimicrobial |
Medical Subject Heading (MeSH) Categories for OFLOXACIN
Anatomical Therapeutic Chemical (ATC) Classes for OFLOXACIN
US Patents and Regulatory Information for OFLOXACIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dr Reddys Labs Ltd | OFLOXACIN | ofloxacin | TABLET;ORAL | 077098-001 | Feb 10, 2006 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Cadila Pharms Ltd | OFLOXACIN | ofloxacin | TABLET;ORAL | 091656-003 | Sep 18, 2014 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Dr Reddys Labs Ltd | OFLOXACIN | ofloxacin | TABLET;ORAL | 077098-002 | Feb 10, 2006 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Chartwell Rx | OFLOXACIN | ofloxacin | TABLET;ORAL | 076093-001 | Sep 2, 2003 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
